Pub Date : 2026-02-01DOI: 10.1016/j.mayocp.2025.12.011
Thom W. Rooke MD
{"title":"Cortisone, Mayo Clinic, and the 1950 Nobel Prize in Medicine: The Seminal Role of Mayo Clinic Proceedings","authors":"Thom W. Rooke MD","doi":"10.1016/j.mayocp.2025.12.011","DOIUrl":"10.1016/j.mayocp.2025.12.011","url":null,"abstract":"","PeriodicalId":18334,"journal":{"name":"Mayo Clinic proceedings","volume":"101 2","pages":"Pages 208-210"},"PeriodicalIF":6.7,"publicationDate":"2026-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146096052","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-02-01DOI: 10.1016/j.mayocp.2025.10.014
Vivek Kumar Prasad MBBS, MPH, PhD , Chibueze Ogbonnaya MS, PhD , Hannah Oh MPH, ScD , Andrew Atkin MS, PhD , Madison Kindred MS, PhD , Min-Jeong Shin PhD , Dahyun Park MS, PhD , Jin Eui Kim BS , Mike Loosemore MBBS, MS, PhD, FFSEM , Vartika Saxena MBBS, MD , Ryan Porter MS, PhD , Courtney Kipps BMBS, MS, MRCS, MRCGP, MFSEM , Jason Jaggers MS, PhD , Xuemei Sui MD, MPH, PhD , Carl J. Lavie MD , Mark Hamer MS, PhD
Objective
To investigate the association of dual-energy X-ray absorptiometry–measured body fat percentage (BF%) and trunk fat mass index (TFMI) with hypertension (HTN), dyslipidemia, and myocardial infarction (MI).
Methods
The relationship between body fat parameters and cardiovascular disease (CVD) was studied across individuals in the same body mass index (BMI) group. Data from the UK Biobank, a multicountry large population-based study, and the US and Korean National Health and Nutrition Examination Surveys, generating nationally representative samples, were pooled and harmonized. This cross-sectional analysis included 30,520 women and 27,244 men aged 40 years or older.
Results
A significant increase in relative risks (RRs) of HTN across BF% quintiles was seen in men with normal weight, overweight, and obesity (P≤.01) and in normal weight women (P<.001). The RRs of dyslipidemia for normal weight and overweight men and women significantly increased across BF% quintiles (P≤.002). The RRs of MI did not exhibit a trend across BF% quintiles for participants within various BMI categories. The RRs of HTN and dyslipidemia significantly increased across TFMI quintiles for men and women with normal weight, overweight, and obesity (P≤.007). In men with normal weight, overweight, and obesity, the RRs of MI significantly increased across TFMI quintiles (P≤.03). However, no trend was displayed in the RRs of MI for women in any BMI group.
Conclusion
This analysis revealed a positive association of dual-energy X-ray absorptiometry–measured body fat parameters with CVDs for individuals in a specific BMI group. The findings highlight a need for policy changes to include directly measured body fatness in assessing CVD risk.
{"title":"Association of Body Fatness With Hypertension, Dyslipidemia, and Myocardial Infarction in a Multinational Pooled Cohort","authors":"Vivek Kumar Prasad MBBS, MPH, PhD , Chibueze Ogbonnaya MS, PhD , Hannah Oh MPH, ScD , Andrew Atkin MS, PhD , Madison Kindred MS, PhD , Min-Jeong Shin PhD , Dahyun Park MS, PhD , Jin Eui Kim BS , Mike Loosemore MBBS, MS, PhD, FFSEM , Vartika Saxena MBBS, MD , Ryan Porter MS, PhD , Courtney Kipps BMBS, MS, MRCS, MRCGP, MFSEM , Jason Jaggers MS, PhD , Xuemei Sui MD, MPH, PhD , Carl J. Lavie MD , Mark Hamer MS, PhD","doi":"10.1016/j.mayocp.2025.10.014","DOIUrl":"10.1016/j.mayocp.2025.10.014","url":null,"abstract":"<div><h3>Objective</h3><div>To investigate the association of dual-energy X-ray absorptiometry–measured body fat percentage (BF%) and trunk fat mass index (TFMI) with hypertension (HTN), dyslipidemia, and myocardial infarction (MI).</div></div><div><h3>Methods</h3><div>The relationship between body fat parameters and cardiovascular disease (CVD) was studied across individuals in the same body mass index (BMI) group. Data from the UK Biobank, a multicountry large population-based study, and the US and Korean National Health and Nutrition Examination Surveys, generating nationally representative samples, were pooled and harmonized. This cross-sectional analysis included 30,520 women and 27,244 men aged 40 years or older.</div></div><div><h3>Results</h3><div>A significant increase in relative risks (RRs) of HTN across BF% quintiles was seen in men with normal weight, overweight, and obesity (<em>P</em>≤.01) and in normal weight women (<em>P</em><.001). The RRs of dyslipidemia for normal weight and overweight men and women significantly increased across BF% quintiles (<em>P</em>≤.002). The RRs of MI did not exhibit a trend across BF% quintiles for participants within various BMI categories. The RRs of HTN and dyslipidemia significantly increased across TFMI quintiles for men and women with normal weight, overweight, and obesity (<em>P</em>≤.007). In men with normal weight, overweight, and obesity, the RRs of MI significantly increased across TFMI quintiles (<em>P</em>≤.03). However, no trend was displayed in the RRs of MI for women in any BMI group.</div></div><div><h3>Conclusion</h3><div>This analysis revealed a positive association of dual-energy X-ray absorptiometry–measured body fat parameters with CVDs for individuals in a specific BMI group. The findings highlight a need for policy changes to include directly measured body fatness in assessing CVD risk.</div></div>","PeriodicalId":18334,"journal":{"name":"Mayo Clinic proceedings","volume":"101 2","pages":"Pages 270-283"},"PeriodicalIF":6.7,"publicationDate":"2026-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145912125","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-02-01DOI: 10.1016/j.mayocp.2024.11.039
Nichole C. Henkes MD , Santiago F. Galeano Lovera MD , Andrew P. Keaveny MD
{"title":"66-Year-Old Man With Altered Mental Status and Cirrhosis","authors":"Nichole C. Henkes MD , Santiago F. Galeano Lovera MD , Andrew P. Keaveny MD","doi":"10.1016/j.mayocp.2024.11.039","DOIUrl":"10.1016/j.mayocp.2024.11.039","url":null,"abstract":"","PeriodicalId":18334,"journal":{"name":"Mayo Clinic proceedings","volume":"101 2","pages":"Pages 335-339"},"PeriodicalIF":6.7,"publicationDate":"2026-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145863754","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-02-01DOI: 10.1016/j.mayocp.2025.10.009
Hesham M. Abdalla MBBS , Adam Bacon MD , Hunter VanDolah MD , Luke Dreher MD , Girish Pathangey MD , Mahmoud Abdelnabi MB, BCh, MSc , Ramzi Ibrahim MD , Milagros Pereyra MD , Juan M. Farina MD , S. Allen Luis MBBS, PhD , Reza Arsanjani MD , Chadi Ayoub MBBS, PhD
Cannabidiol (CBD), a non-psychoactive phytocannabinoid derived from Cannabis sativa, has gained significant interest for its potential therapeutic applications in cardiovascular disease. Through interactions with various molecular targets, CBD demonstrates potential for anti-inflammatory, antioxidant, and vasodilatory properties, supporting a potential role in the management of pericarditis and inflammatory cardiac conditions, ischemic heart disease (IHD), and heart failure. Integrating preclinical and emerging clinical evidence, this review explores the role of CBD in mitigating ischemia-reperfusion injury, myocardial fibrosis, and cardiac arrhythmias, with preliminary trials showing its potential as a nonimmunosuppressive therapy for recurrent pericarditis and myocarditis. Despite promising evidence, clinical application of CBD is hindered by limited trials, dosing inconsistencies, and ongoing safety and regulatory challenges. This review delves into these limitations, identifying key research gaps and future directions needed to establish the clinical utility, safety, and therapeutic efficacy of CBD in cardiovascular medicine.
{"title":"Cannabidiol in Cardiovascular Disease: A Review of Current Evidence and Future Directions","authors":"Hesham M. Abdalla MBBS , Adam Bacon MD , Hunter VanDolah MD , Luke Dreher MD , Girish Pathangey MD , Mahmoud Abdelnabi MB, BCh, MSc , Ramzi Ibrahim MD , Milagros Pereyra MD , Juan M. Farina MD , S. Allen Luis MBBS, PhD , Reza Arsanjani MD , Chadi Ayoub MBBS, PhD","doi":"10.1016/j.mayocp.2025.10.009","DOIUrl":"10.1016/j.mayocp.2025.10.009","url":null,"abstract":"<div><div>Cannabidiol (CBD), a non-psychoactive phytocannabinoid derived from <em>Cannabis sativa</em>, has gained significant interest for its potential therapeutic applications in cardiovascular disease. Through interactions with various molecular targets, CBD demonstrates potential for anti-inflammatory, antioxidant, and vasodilatory properties, supporting a potential role in the management of pericarditis and inflammatory cardiac conditions, ischemic heart disease (IHD), and heart failure. Integrating preclinical and emerging clinical evidence, this review explores the role of CBD in mitigating ischemia-reperfusion injury, myocardial fibrosis, and cardiac arrhythmias, with preliminary trials showing its potential as a nonimmunosuppressive therapy for recurrent pericarditis and myocarditis. Despite promising evidence, clinical application of CBD is hindered by limited trials, dosing inconsistencies, and ongoing safety and regulatory challenges. This review delves into these limitations, identifying key research gaps and future directions needed to establish the clinical utility, safety, and therapeutic efficacy of CBD in cardiovascular medicine.</div></div>","PeriodicalId":18334,"journal":{"name":"Mayo Clinic proceedings","volume":"101 2","pages":"Pages 297-309"},"PeriodicalIF":6.7,"publicationDate":"2026-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145856989","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-02-01DOI: 10.1016/j.mayocp.2025.06.022
Zhuo Chen MD, PhD , Jingen Li MD, PhD , Betsy J. Medina-Inojosa MD , Jose R. Medina-Inojosa MD, MSc , Kyla M. Lara-Breitinger MD , Virend K. Somers MD, PhD , Andres Acosta MD, PhD , Amir Lerman MD , Francisco Lopez-Jimenez MD, MSc
Objective
To test the hypothesis that body adiposity measured by dual x-ray absorptiometry is associated with metabolic disorders and all-cause mortality in normal-weight individuals.
Methods
Adults 20 to 65 years of age with normal body mass index (BMI) and dual x-ray absorptiometry examination in the US National Health and Nutrition Examination Survey from 1999-2006 and 2011-2018 were evaluated. Follow-up was until December 2019. Weighted logistic regression and Cox proportional hazard models were performed to test the association between body fat percentage (BF%) and metabolic disorders (ie, insulin resistance, metabolic syndrome, dyslipidemia, type 2 diabetes mellitus, and hypertension) and mortality. Models were adjusted for potential confounders while considering complex survey design and were further stratified by sex and BF% as tertiles in normal-weight individuals.
Results
Included in this study sample were 20,613 individuals of whom 6424 were normal weight by BMI (18.5-24.9 kg/m2) (45.7% men, 69.6% non-Hispanic Whites). Every 10-unit percent increase in total BF% was associated with a higher risk for insulin resistance, metabolic syndrome, dyslipidemia, and all-cause mortality in the normal BMI group. Metabolic disorders were associated with BF% tertiles.
Conclusion
Even in these normal weight subjects, increases in body adiposity are significantly associated with increased cardiometabolic disease burden and mortality.
{"title":"Body Fat and Cardiometabolic Disease Burden and All-Cause Mortality in Adults With Normal Body Mass Index","authors":"Zhuo Chen MD, PhD , Jingen Li MD, PhD , Betsy J. Medina-Inojosa MD , Jose R. Medina-Inojosa MD, MSc , Kyla M. Lara-Breitinger MD , Virend K. Somers MD, PhD , Andres Acosta MD, PhD , Amir Lerman MD , Francisco Lopez-Jimenez MD, MSc","doi":"10.1016/j.mayocp.2025.06.022","DOIUrl":"10.1016/j.mayocp.2025.06.022","url":null,"abstract":"<div><h3>Objective</h3><div>To test the hypothesis that body adiposity measured by dual x-ray absorptiometry is associated with metabolic disorders and all-cause mortality in normal-weight individuals.</div></div><div><h3>Methods</h3><div>Adults 20 to 65 years of age with normal body mass index (BMI) and dual x-ray absorptiometry examination in the US National Health and Nutrition Examination Survey from 1999-2006 and 2011-2018 were evaluated. Follow-up was until December 2019. Weighted logistic regression and Cox proportional hazard models were performed to test the association between body fat percentage (BF%) and metabolic disorders (ie, insulin resistance, metabolic syndrome, dyslipidemia, type 2 diabetes mellitus, and hypertension) and mortality. Models were adjusted for potential confounders while considering complex survey design and were further stratified by sex and BF% as tertiles in normal-weight individuals.</div></div><div><h3>Results</h3><div>Included in this study sample were 20,613 individuals of whom 6424 were normal weight by BMI (18.5-24.9 kg/m<sup>2</sup>) (45.7% men, 69.6% non-Hispanic Whites). Every 10-unit percent increase in total BF% was associated with a higher risk for insulin resistance, metabolic syndrome, dyslipidemia, and all-cause mortality in the normal BMI group. Metabolic disorders were associated with BF% tertiles.</div></div><div><h3>Conclusion</h3><div>Even in these normal weight subjects, increases in body adiposity are significantly associated with increased cardiometabolic disease burden and mortality.</div></div>","PeriodicalId":18334,"journal":{"name":"Mayo Clinic proceedings","volume":"101 2","pages":"Pages 249-258"},"PeriodicalIF":6.7,"publicationDate":"2026-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146096055","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
To explore the association between a Planetary Health Diet Index (PHDI) and the risk of chronic kidney disease (CKD).
Methods
Data were analyzed from 98,374 middle-aged adults from the UK Biobank cohort without CKD and were followed up from July 13, 2011, to November 8, 2021. Using at least two 24-hour dietary assessments, we calculated the PHDI score, ranging from 0 to 130 points (highest adherence) based on 14 food groups. Cases of CKD were obtained from primary care, hospital, and death records. We used multivariable Cox models to estimate hazard ratios (HRs) and their 95% confidence intervals (95% CIs) to analyze the study associations.
Results
During a median 9.41-year follow-up, CKD developed in 2635 (2.7%) participants. Comparing the highest with the lowest adherence quintile of the PHDI, the fully adjusted HR (95% CI) for CKD risk was 0.74 (0.65 to 0.85). Results remained robust in sensitivity analyses. The major contributors to the lower CKD risk were high consumption of vegetables (HR per 2-point increment, 0.97 [0.94 to 0.99]), fruits (0.97 [0.95 to 0.99]), and whole grains (0.97 [0.96 to 0.99]) and low consumption of starchy vegetables (0.98 [0.95 to 1.00]), poultry (0.98 [0.95 to 1.00]), and added sugars and fruit juices (0.93 [0.88 to 0.98]).
Conclusion
In this cohort of middle-aged and older British adults, greater adherence to the PHDI was associated with a lower CKD risk. Promoting this environmentally sustainable dietary pattern may also help reduce the burden of CKD.
{"title":"Adherence to a Planetary Health Diet and Risk of Chronic Kidney Disease: A Longitudinal Cohort Study From the UK Biobank","authors":"Mercedes Gómez-Cao MSc , Javier Maroto-Rodriguez MSc , Rosario Ortolá MD, PhD , Adrián Carballo-Casla PhD , Fernando Rodriguez-Artalejo MD, PhD , Mercedes Sotos-Prieto PhD","doi":"10.1016/j.mayocp.2025.07.035","DOIUrl":"10.1016/j.mayocp.2025.07.035","url":null,"abstract":"<div><h3>Objective</h3><div>To explore the association between a Planetary Health Diet Index (PHDI) and the risk of chronic kidney disease (CKD).</div></div><div><h3>Methods</h3><div>Data were analyzed from 98,374 middle-aged adults from the UK Biobank cohort without CKD and were followed up from July 13, 2011, to November 8, 2021. Using at least two 24-hour dietary assessments, we calculated the PHDI score, ranging from 0 to 130 points (highest adherence) based on 14 food groups. Cases of CKD were obtained from primary care, hospital, and death records. We used multivariable Cox models to estimate hazard ratios (HRs) and their 95% confidence intervals (95% CIs) to analyze the study associations.</div></div><div><h3>Results</h3><div>During a median 9.41-year follow-up, CKD developed in 2635 (2.7%) participants. Comparing the highest with the lowest adherence quintile of the PHDI, the fully adjusted HR (95% CI) for CKD risk was 0.74 (0.65 to 0.85). Results remained robust in sensitivity analyses. The major contributors to the lower CKD risk were high consumption of vegetables (HR per 2-point increment, 0.97 [0.94 to 0.99]), fruits (0.97 [0.95 to 0.99]), and whole grains (0.97 [0.96 to 0.99]) and low consumption of starchy vegetables (0.98 [0.95 to 1.00]), poultry (0.98 [0.95 to 1.00]), and added sugars and fruit juices (0.93 [0.88 to 0.98]).</div></div><div><h3>Conclusion</h3><div>In this cohort of middle-aged and older British adults, greater adherence to the PHDI was associated with a lower CKD risk. Promoting this environmentally sustainable dietary pattern may also help reduce the burden of CKD.</div></div>","PeriodicalId":18334,"journal":{"name":"Mayo Clinic proceedings","volume":"101 2","pages":"Pages 224-236"},"PeriodicalIF":6.7,"publicationDate":"2026-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145856986","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-02-01DOI: 10.1016/j.mayocp.2025.09.021
Setor K. Kunutsor MD, PhD , Sae Young Jae PhD , Jari A. Laukkanen MD, PhD
Objective
To investigate the prospective association of the visceral adiposity index (VAI) with the risk of cardiometabolic multimorbidity (CMM) and to evaluate its utility in CMM risk prediction.
Methods
We analyzed data from 3348 adults (mean age, 63 years; 45.1% male) participating in the English Longitudinal Study of Ageing who were free from hypertension, coronary heart disease, diabetes, and stroke at wave 4 (2008-2009). Visceral adiposity index was calculated with anthropometric and metabolic parameters. Cardiometabolic multimorbidity was defined as the presence of 2 or more of the following conditions at wave 10 (2021-2023): hypertension, cardiovascular disease, diabetes, or stroke. Multivariable logistic regression models were used to estimate odds ratios and 95% CIs.
Results
During a 12- to 15-year follow-up period, CMM developed in 197 participants. Restricted cubic spline analysis found a predominantly linear pattern between the VAI and CMM risk (P value for nonlinearity, .062). Each 1 SD increment in VAI was associated with higher odds of CMM (odds ratio, 1.33; 95% CI, 1.19 to 1.50) after adjustment for age, sex, smoking, alcohol intake, systolic blood pressure, total cholesterol level, and handgrip strength. This association persisted after further adjustment for physical activity. The associations were qualitatively similar across VAI tertiles. The VAI significantly improved risk discrimination beyond established risk factors (C-index change, 0.0205 [P=.021] and P value for difference in −2 log likelihood <.001).
Conclusion
There is a positive association between VAI and CMM risk that is independent of established risk factors and consistent with a linear dose-response pattern. The VAI provides significant improvement in CMM risk prediction beyond established risk factors.
{"title":"Visceral Adiposity Index Is Associated With Cardiometabolic Multimorbidity and Improves Risk Prediction: The English Longitudinal Study of Ageing","authors":"Setor K. Kunutsor MD, PhD , Sae Young Jae PhD , Jari A. Laukkanen MD, PhD","doi":"10.1016/j.mayocp.2025.09.021","DOIUrl":"10.1016/j.mayocp.2025.09.021","url":null,"abstract":"<div><h3>Objective</h3><div>To investigate the prospective association of the visceral adiposity index (VAI) with the risk of cardiometabolic multimorbidity (CMM) and to evaluate its utility in CMM risk prediction.</div></div><div><h3>Methods</h3><div>We analyzed data from 3348 adults (mean age, 63 years; 45.1% male) participating in the English Longitudinal Study of Ageing who were free from hypertension, coronary heart disease, diabetes, and stroke at wave 4 (2008-2009). Visceral adiposity index was calculated with anthropometric and metabolic parameters. Cardiometabolic multimorbidity was defined as the presence of 2 or more of the following conditions at wave 10 (2021-2023): hypertension, cardiovascular disease, diabetes, or stroke. Multivariable logistic regression models were used to estimate odds ratios and 95% CIs.</div></div><div><h3>Results</h3><div>During a 12- to 15-year follow-up period, CMM developed in 197 participants. Restricted cubic spline analysis found a predominantly linear pattern between the VAI and CMM risk (<em>P</em> value for nonlinearity, .062). Each 1 SD increment in VAI was associated with higher odds of CMM (odds ratio, 1.33; 95% CI, 1.19 to 1.50) after adjustment for age, sex, smoking, alcohol intake, systolic blood pressure, total cholesterol level, and handgrip strength. This association persisted after further adjustment for physical activity. The associations were qualitatively similar across VAI tertiles. The VAI significantly improved risk discrimination beyond established risk factors (C-index change, 0.0205 [<em>P</em>=.021] and <em>P</em> value for difference in −2 log likelihood <.001).</div></div><div><h3>Conclusion</h3><div>There is a positive association between VAI and CMM risk that is independent of established risk factors and consistent with a linear dose-response pattern. The VAI provides significant improvement in CMM risk prediction beyond established risk factors.</div></div>","PeriodicalId":18334,"journal":{"name":"Mayo Clinic proceedings","volume":"101 2","pages":"Pages 259-269"},"PeriodicalIF":6.7,"publicationDate":"2026-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145857080","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-02-01DOI: 10.1016/j.mayocp.2025.12.004
Margaret R. Wentz BA
Art is integrated into the Mayo Clinic environment. Since the original Mayo Clinic Building was finished in 1914, many pieces have been donated or commissioned for patients and staff to enjoy. Each issue of Mayo Clinic Proceedings features a work of art (as interpreted by the author) that is displayed in a building or on the grounds of Mayo Clinic campuses.
{"title":"Transparent Man by Artisans at the Deutsches Hygiene Museum","authors":"Margaret R. Wentz BA","doi":"10.1016/j.mayocp.2025.12.004","DOIUrl":"10.1016/j.mayocp.2025.12.004","url":null,"abstract":"<div><div>Art is integrated into the Mayo Clinic environment. Since the original Mayo Clinic Building was finished in 1914, many pieces have been donated or commissioned for patients and staff to enjoy. Each issue of <em>Mayo Clinic Proceedings</em> features a work of art (as interpreted by the author) that is displayed in a building or on the grounds of Mayo Clinic campuses.</div></div>","PeriodicalId":18334,"journal":{"name":"Mayo Clinic proceedings","volume":"101 2","pages":"Pages 355-356"},"PeriodicalIF":6.7,"publicationDate":"2026-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146096045","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
扫码关注我们
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号